Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 300

1.

Precocious neuronal differentiation and disrupted oxygen responses in Kabuki syndrome.

Carosso GA, Boukas L, Augustin JJ, Nguyen HN, Winer BL, Cannon GH, Robertson JD, Zhang L, Hansen KD, Goff LA, Bjornsson HT.

JCI Insight. 2019 Oct 17;4(20). pii: 129375. doi: 10.1172/jci.insight.129375.

2.

Gold Nanoparticle Transforms Activated Cancer-Associated Fibroblasts to Quiescence.

Hossen MN, Rao G, Dey A, Robertson JD, Bhattacharya R, Mukherjee P.

ACS Appl Mater Interfaces. 2019 Jul 24;11(29):26060-26068. doi: 10.1021/acsami.9b03313. Epub 2019 Jul 11.

PMID:
31117437
3.

Extreme skewing of X-inactivation: Rethinking severe haemophilia in women and girls.

Mason JA, Robertson JD.

Haemophilia. 2019 Jul;25(4):e286-e287. doi: 10.1111/hae.13755. Epub 2019 Apr 17. No abstract available.

PMID:
30993824
4.

Boron-neutron Capture on Activated Carbon for Hydrogen Storage.

Romanos J, Beckner M, Prosniewski M, Rash T, Lee M, Robertson JD, Firlej L, Kuchta B, Pfeifer P.

Sci Rep. 2019 Feb 27;9(1):2971. doi: 10.1038/s41598-019-39417-6.

5.

The surprisingly large neutron capture cross-section of 88Zr.

Shusterman JA, Scielzo ND, Thomas KJ, Norman EB, Lapi SE, Loveless CS, Peters NJ, Robertson JD, Shaughnessy DA, Tonchev AP.

Nature. 2019 Jan;565(7739):328-330. doi: 10.1038/s41586-018-0838-z. Epub 2019 Jan 7.

PMID:
30617314
6.

Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes.

Hodgson DR, Dougherty BA, Lai Z, Fielding A, Grinsted L, Spencer S, O'Connor MJ, Ho TW, Robertson JD, Lanchbury JS, Timms KM, Gutin A, Orr M, Jones H, Gilks B, Womack C, Gourley C, Ledermann J, Barrett JC.

Br J Cancer. 2018 Nov;119(11):1401-1409. doi: 10.1038/s41416-018-0274-8. Epub 2018 Oct 24.

7.

Self-healing effects in a semi-ordered liquid for stable electronic conversion of high-energy radiation.

Nullmeyer BR, Kwon JW, Robertson JD, Garnov AY.

Sci Rep. 2018 Aug 17;8(1):12404. doi: 10.1038/s41598-018-30815-w.

8.

Demonstration of a novel Xp22.2 microdeletion as the cause of familial extreme skewing of X-inactivation utilizing case-parent trio SNP microarray analysis.

Mason JA, Aung HT, Nandini A, Woods RG, Fairbairn DJ, Rowell JA, Young D, Susman RD, Brown SA, Hyland VJ, Robertson JD.

Mol Genet Genomic Med. 2018 May;6(3):357-369. doi: 10.1002/mgg3.378. Epub 2018 Feb 28.

9.

Synthesis and targeting of gold-coated 177Lu-containing lanthanide phosphate nanoparticles-A potential theranostic agent for pulmonary metastatic disease.

Sobol N, Sutherlin L, Cedrowska E, Schorp J, Rodríguez-Rodríguez C, Sossi V, Lattimer J, Miller DC, Pevsner P, Robertson JD.

APL Bioeng. 2017 Dec 27;2(1):016101. doi: 10.1063/1.5018165. eCollection 2018 Mar.

10.

Cadmium exposure and endometrial cancer risk: A large midwestern U.S. population-based case-control study.

McElroy JA, Kruse RL, Guthrie J, Gangnon RE, Robertson JD.

PLoS One. 2017 Jul 24;12(7):e0179360. doi: 10.1371/journal.pone.0179360. eCollection 2017.

11.

Measurement of 239Pu in keratinous materials: A potential non-invasive bioassay for monitoring human exposure.

Brown JWN, Brockman JD, Robertson JD.

Appl Radiat Isot. 2017 Oct;128:132-135. doi: 10.1016/j.apradiso.2017.06.047. Epub 2017 Jul 1.

PMID:
28710932
12.

Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting.

Dougherty BA, Lai Z, Hodgson DR, Orr MCM, Hawryluk M, Sun J, Yelensky R, Spencer SK, Robertson JD, Ho TW, Fielding A, Ledermann JA, Barrett JC.

Oncotarget. 2017 Jul 4;8(27):43653-43661. doi: 10.18632/oncotarget.17613.

13.

In vivo transport of three radioactive [18F]-fluorinated deoxysucrose analogs by the maize sucrose transporter ZmSUT1.

Tran TM, Hampton CS, Brossard TW, Harmata M, Robertson JD, Jurisson SS, Braun DM.

Plant Physiol Biochem. 2017 Jun;115:1-11. doi: 10.1016/j.plaphy.2017.03.006. Epub 2017 Mar 8.

PMID:
28300727
14.

Targeting Neutrophilic Inflammation Using Polymersome-Mediated Cellular Delivery.

Robertson JD, Ward JR, Avila-Olias M, Battaglia G, Renshaw SA.

J Immunol. 2017 May 1;198(9):3596-3604. doi: 10.4049/jimmunol.1601901. Epub 2017 Mar 13.

15.

Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization.

Lheureux S, Lai Z, Dougherty BA, Runswick S, Hodgson DR, Timms KM, Lanchbury JS, Kaye S, Gourley C, Bowtell D, Kohn EC, Scott C, Matulonis U, Panzarella T, Karakasis K, Burnier JV, Gilks CB, O'Connor MJ, Robertson JD, Ledermann J, Barrett JC, Ho TW, Oza AM.

Clin Cancer Res. 2017 Aug 1;23(15):4086-4094. doi: 10.1158/1078-0432.CCR-16-2615. Epub 2017 Feb 21.

16.

Ionic Liquid-Assisted Synthesis of Nanoscale (MoS2)x(SnO2)1-x on Reduced Graphene Oxide for the Electrocatalytic Hydrogen Evolution Reaction.

Ravula S, Zhang C, Essner JB, Robertson JD, Lin J, Baker GA.

ACS Appl Mater Interfaces. 2017 Mar 8;9(9):8065-8074. doi: 10.1021/acsami.6b13578. Epub 2017 Feb 21.

PMID:
28187262
17.

Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth.

Saha S, Xiong X, Chakraborty PK, Shameer K, Arvizo RR, Kudgus RA, Dwivedi SK, Hossen MN, Gillies EM, Robertson JD, Dudley JT, Urrutia RA, Postier RG, Bhattacharya R, Mukherjee P.

ACS Nano. 2016 Dec 27;10(12):10636-10651. doi: 10.1021/acsnano.6b02231. Epub 2016 Oct 19.

PMID:
27758098
18.

Hepatocellular Carcinoma: Intra-arterial Delivery of Doxorubicin-loaded Hollow Gold Nanospheres for Photothermal Ablation-Chemoembolization Therapy in Rats.

Li J, Zhou M, Liu F, Xiong C, Wang W, Cao Q, Wen X, Robertson JD, Ji X, Wang YA, Gupta S, Li C.

Radiology. 2016 Nov;281(2):427-435. Epub 2016 Jun 27.

19.

Measurement of Uranium Isotope Ratios in Keratinous Materials: A Noninvasive Bioassay for Special Nuclear Material.

Brockman JD, Brown JW, Morrell JS, Robertson JD.

Anal Chem. 2016 Sep 6;88(17):8765-71. doi: 10.1021/acs.analchem.6b02144. Epub 2016 Aug 16.

PMID:
27484415
20.

Successful management of ischemic cholangiopathy after failed endoscopic/percutaneous interventions, facilitated by digital cholangioscopy.

Raghavapuram S, Girotra M, Robertson JD, Pandey T, Tharian B.

Gastrointest Endosc. 2016 Dec;84(6):1053-1054. doi: 10.1016/j.gie.2016.07.011. Epub 2016 Jul 20. No abstract available.

PMID:
27449196
21.

Assessment and validation of a defined fluid restriction protocol in the use of subcutaneous desmopressin for children with inherited bleeding disorders.

Mason JA, Robertson JD, McCosker J, Williams BA, Brown SA.

Haemophilia. 2016 Sep;22(5):700-5. doi: 10.1111/hae.12949. Epub 2016 Jul 6.

PMID:
27385253
22.

Purification of Nanoparticles by Size and Shape.

Robertson JD, Rizzello L, Avila-Olias M, Gaitzsch J, Contini C, Magoń MS, Renshaw SA, Battaglia G.

Sci Rep. 2016 Jun 8;6:27494. doi: 10.1038/srep27494.

23.

Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety.

Matulonis UA, Penson RT, Domchek SM, Kaufman B, Shapira-Frommer R, Audeh MW, Kaye S, Molife LR, Gelmon KA, Robertson JD, Mann H, Ho TW, Coleman RL.

Ann Oncol. 2016 Jun;27(6):1013-9. doi: 10.1093/annonc/mdw133. Epub 2016 Mar 8.

PMID:
26961146
24.

Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy.

Domchek SM, Aghajanian C, Shapira-Frommer R, Schmutzler RK, Audeh MW, Friedlander M, Balmaña J, Mitchell G, Fried G, Stemmer SM, Hubert A, Rosengarten O, Loman N, Robertson JD, Mann H, Kaufman B.

Gynecol Oncol. 2016 Feb;140(2):199-203. doi: 10.1016/j.ygyno.2015.12.020. Epub 2015 Dec 23.

25.

Gelatinase activity imaged by activatable cell-penetrating peptides in cell-based and in vivo models of stroke.

Chen S, Cui J, Jiang T, Olson ES, Cai QY, Yang M, Wu W, Guthrie JM, Robertson JD, Lipton SA, Ma L, Tsien RY, Gu Z.

J Cereb Blood Flow Metab. 2017 Jan;37(1):188-200. Epub 2015 Dec 17.

26.

Pediatric transplantation: preventing thrombosis.

Robertson JD.

J Thromb Haemost. 2015 Jun;13 Suppl 1:S351-61. doi: 10.1111/jth.12968. Review.

27.

Radiosynthesis of 6'-Deoxy-6'[18F]Fluorosucrose via Automated Synthesis and Its Utility to Study In Vivo Sucrose Transport in Maize (Zea mays) Leaves.

Rotsch D, Brossard T, Bihmidine S, Ying W, Gaddam V, Harmata M, Robertson JD, Swyers M, Jurisson SS, Braun DM.

PLoS One. 2015 May 29;10(5):e0128989. doi: 10.1371/journal.pone.0128989. eCollection 2015.

28.

The DAF-16 FOXO transcription factor regulates natc-1 to modulate stress resistance in Caenorhabditis elegans, linking insulin/IGF-1 signaling to protein N-terminal acetylation.

Warnhoff K, Murphy JT, Kumar S, Schneider DL, Peterson M, Hsu S, Guthrie J, Robertson JD, Kornfeld K.

PLoS Genet. 2014 Oct 16;10(10):e1004703. doi: 10.1371/journal.pgen.1004703. eCollection 2014 Oct.

29.
30.

Measurement of U and Pu isotope ratios in hair and nail samples using extraction chromatography and multi-collector inductively coupled plasma mass spectrometry.

Brown JN 4th, Robertson JD, Brockman JD.

Talanta. 2014 Nov;129:481-5. doi: 10.1016/j.talanta.2014.06.015. Epub 2014 Jun 18.

PMID:
25127622
31.

Serum protein profiling reveals baseline and pharmacodynamic biomarker signatures associated with clinical outcome in mCRC patients treated with chemotherapy ± cediranib.

Pommier AJ, Shaw R, Spencer SK, Morgan SR, Hoff PM, Robertson JD, Barry ST, Jürgensmeier JM.

Br J Cancer. 2014 Oct 14;111(8):1590-604. doi: 10.1038/bjc.2014.436. Epub 2014 Aug 14.

32.

Bombesin peptide conjugated gold nanocages internalize via clathrin mediated endocytosis.

Suresh D, Zambre A, Chanda N, Hoffman TJ, Smith CJ, Robertson JD, Kannan R.

Bioconjug Chem. 2014 Aug 20;25(8):1565-79. doi: 10.1021/bc500295s. Epub 2014 Jul 29.

PMID:
25020251
33.

Tuning pharmacokinetics and biodistribution of a targeted drug delivery system through incorporation of a passive targeting component.

Kudgus RA, Walden CA, McGovern RM, Reid JM, Robertson JD, Mukherjee P.

Sci Rep. 2014 Jul 11;4:5669. doi: 10.1038/srep05669.

34.

Pharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheres.

You J, Zhou J, Zhou M, Liu Y, Robertson JD, Liang D, Van Pelt C, Li C.

Part Fibre Toxicol. 2014 May 30;11:26. doi: 10.1186/1743-8977-11-26.

35.

pH-sensitive tubular polymersomes: formation and applications in cellular delivery.

Robertson JD, Yealland G, Avila-Olias M, Chierico L, Bandmann O, Renshaw SA, Battaglia G.

ACS Nano. 2014 May 27;8(5):4650-61. doi: 10.1021/nn5004088. Epub 2014 Apr 29.

PMID:
24724711
36.

Specific activity measurement of ⁶⁴Cu: a comparison of methods.

Mastren T, Guthrie J, Eisenbeis P, Voller T, Mebrahtu E, Robertson JD, Lapi SE.

Appl Radiat Isot. 2014 Aug;90:117-21. doi: 10.1016/j.apradiso.2014.03.016. Epub 2014 Mar 20.

PMID:
24709610
37.

VgrG-5 is a Burkholderia type VI secretion system-exported protein required for multinucleated giant cell formation and virulence.

Schwarz S, Singh P, Robertson JD, LeRoux M, Skerrett SJ, Goodlett DR, West TE, Mougous JD.

Infect Immun. 2014 Apr;82(4):1445-52. doi: 10.1128/IAI.01368-13. Epub 2014 Jan 22.

38.

BH3-only protein BIM mediates heat shock-induced apoptosis.

Mahajan IM, Chen MD, Muro I, Robertson JD, Wright CW, Bratton SB.

PLoS One. 2014 Jan 10;9(1):e84388. doi: 10.1371/journal.pone.0084388. eCollection 2014.

39.

The role of NOD2 in murine and human melioidosis.

Myers ND, Chantratita N, Berrington WR, Chierakul W, Limmathurotsakul D, Wuthiekanun V, Robertson JD, Liggitt HD, Peacock SJ, Skerrett SJ, West TE.

J Immunol. 2014 Jan 1;192(1):300-7. doi: 10.4049/jimmunol.1301436. Epub 2013 Dec 2.

40.

Screen of whole blood responses to flagellin identifies TLR5 variation associated with outcome in melioidosis.

Chantratita N, Tandhavanant S, Myers ND, Chierakul W, Robertson JD, Mahavanakul W, Singhasivanon P, Emond MJ, Peacock SJ, West TE.

Genes Immun. 2014 Mar;15(2):63-71. doi: 10.1038/gene.2013.60. Epub 2013 Nov 28.

41.

Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy.

Spencer SK, Pommier AJ, Morgan SR, Barry ST, Robertson JD, Hoff PM, Jürgensmeier JM.

Br J Cancer. 2013 Nov 26;109(11):2765-73. doi: 10.1038/bjc.2013.649. Epub 2013 Oct 22.

42.

Point-of-care derived INR does not reliably detect significant coagulopathy following Australian snakebite.

O'Rourke KM, Correlje E, Martin CL, Robertson JD, Isbister GK.

Thromb Res. 2013 Nov;132(5):610-3. doi: 10.1016/j.thromres.2013.09.004. Epub 2013 Sep 10.

PMID:
24075725
43.

Chronic pravastatin but not atorvastatin treatment impairs cognitive function in two rodent models of learning and memory.

Stuart SA, Robertson JD, Marrion NV, Robinson ES.

PLoS One. 2013 Sep 10;8(9):e75467. doi: 10.1371/journal.pone.0075467. eCollection 2013.

44.

ttm-1 encodes CDF transporters that excrete zinc from intestinal cells of C. elegans and act in a parallel negative feedback circuit that promotes homeostasis.

Roh HC, Collier S, Deshmukh K, Guthrie J, Robertson JD, Kornfeld K.

PLoS Genet. 2013 May;9(5):e1003522. doi: 10.1371/journal.pgen.1003522. Epub 2013 May 23.

45.

Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle.

Arvizo RR, Saha S, Wang E, Robertson JD, Bhattacharya R, Mukherjee P.

Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6700-5. doi: 10.1073/pnas.1214547110. Epub 2013 Apr 8.

46.

KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib.

Smith JC, Brooks L, Hoff PM, McWalter G, Dearden S, Morgan SR, Wilson D, Robertson JD, Jürgensmeier JM.

Eur J Cancer. 2013 Jul;49(10):2424-32. doi: 10.1016/j.ejca.2013.02.023. Epub 2013 Mar 16.

PMID:
23510802
47.

Inhibiting the growth of pancreatic adenocarcinoma in vitro and in vivo through targeted treatment with designer gold nanotherapeutics.

Kudgus RA, Szabolcs A, Khan JA, Walden CA, Reid JM, Robertson JD, Bhattacharya R, Mukherjee P.

PLoS One. 2013;8(3):e57522. doi: 10.1371/journal.pone.0057522. Epub 2013 Mar 6.

48.

Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy.

Jürgensmeier JM, Schmoll HJ, Robertson JD, Brooks L, Taboada M, Morgan SR, Wilson D, Hoff PM.

Br J Cancer. 2013 Apr 2;108(6):1316-23. doi: 10.1038/bjc.2013.79. Epub 2013 Feb 28.

49.

Gold coated lanthanide phosphate nanoparticles for targeted alpha generator radiotherapy.

McLaughlin MF, Woodward J, Boll RA, Wall JS, Rondinone AJ, Kennel SJ, Mirzadeh S, Robertson JD.

PLoS One. 2013;8(1):e54531. doi: 10.1371/journal.pone.0054531. Epub 2013 Jan 18.

50.

Requirement of apoptotic protease-activating factor-1 for bortezomib-induced apoptosis but not for Fas-mediated apoptosis in human leukemic cells.

Ottosson-Wadlund A, Ceder R, Preta G, Pokrovskaja K, Grafström RC, Heyman M, Söderhäll S, Grandér D, Hedenfalk I, Robertson JD, Fadeel B.

Mol Pharmacol. 2013 Jan;83(1):245-55. doi: 10.1124/mol.112.080788. Epub 2012 Oct 23.

PMID:
23093495

Supplemental Content

Loading ...
Support Center